Incorporating Real-Time - Integrated CGM: Opportunities in the Pharmacy to Improve Quality of Life for Patients With Diabetes (Pharmacist Credit)

Incorporating Real-Time–Integrated CGM: Opportunities in the Pharmacy to Improve Quality of Life for Patients With Diabetes

On-Demand 1.5-hour Accredited Webcast

Moderator

Dhiren Patel, PharmD, CDCES, BC-ADM
Adjunct Associate Professor of Pharmacy Practice
MCPHS University – Boston
Endocrine Clinical Pharmacy Specialist
Cardiometabolic Concierge Clinic
Boston, Massachusetts

Faculty Presenters

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
Endocrinology Clinical Pharmacy Specialist
CGM and Remote Monitoring Program Coordinator
Cleveland Clinic Endocrinology and Metabolism Institute
Cleveland, Ohio

Erin Shaal, PharmD
Senior Director, Pharmacy Procurement
Albertsons Companies
Boise, Idaho

Samir Mistry, PharmD
Vice President of Pharmacy
PreferredOne
Golden Valley, Minnesota

Medical Writer for Panel Discussion

Nisha Bhide, PharmD, BCPS
Director, Formulary Operations
Capital Rx
New York, New York

Medical Writer for Video Vignette Scripts

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
Endocrinology Clinical Pharmacy Specialist
CGM and Remote Monitoring Program Coordinator
Cleveland Clinic Endocrinology and Metabolism Institute
Cleveland, Ohio
 
Program Description
Continuous glucose monitoring (CGM) devices are increasingly being made available through various pharmacy settings and have offered an opportunity to improve overall quality of life for patients with diabetes. The technological features of real-time–integrated (rt-iCGM) devices have a significant role in diabetes management, from the data they provide to the alerts and alarms that can be customized for individual patients. Regardless of the setting they practice in, pharmacists can work directly with patients and providers to minimize costs and offer important education and counseling points on the optimal use of CGM technology. They play a significant role in identifying patients who may benefit from rt-iCGM devices, being aware of expanded patient populations where these devices may be appropriate, making appropriate interventions to better control HbA1c levels, and facilitating access to rt-iCGM devices. Part 2 of this series continues the interactive discussion with expert panelists and highlights various patient counseling video vignettes that focus on patient education and how rt-iCGM technology has helped improve outcomes for patients with diabetes.

Target audience:  Health-system, managed care, retail, and specialty pharmacists, and pharmacy technicians
Type of activity: Application for pharmacists; Knowledge for pharmacy technicians
Release date: June 30, 2021
Expiration date: June 30, 2022
Time to complete activity: 1.5 hours
Fee: Free

Educational Objectives for Pharmacists
At the completion of this activity, participants will be able to:

• Explore the economic burden and impact on quality of life for patients with diabetes and the role of real-time continuous glucose monitoring (rtCGM) in addressing these barriers
• Explain the 2021 updates and recommendations around CGM use for patients with diabetes including information from recent guidelines and conferences
• Identify when it may be appropriate for pharmacists to recommend use of rtCGM and analyze expanding evidence for special patient populations
• Determine various opportunities for pharmacists to provide access to rtCGM

Educational Objectives for Pharmacy Technicians
At the completion of this activity, participants will be able to:

• Outline the economic burden and impact on quality of life for patients with diabetes and the role of real-time continuous glucose monitoring (rtCGM) in addressing these barriers
• Explain the 2021 updates and recommendations around CGM use for patients with diabetes including information from recent guidelines and conferences
• Detail various opportunities for pharmacy technicians to help facilitate providing access to rtCGM 

 Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity numbers 0290-0000-21-270-H01-P and 0290-0000-21-271-H01-T. The activity is available for CE credit through June 30, 2022.


Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the webcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
 

---

Disclosures

Faculty

Dhiren Patel, PharmD, CDCES, BC-ADM, has the following relevant financial relationships with commercial interests to disclose:

• Consultant: Bayer, Insulet, Lilly, Novo Nordisk
• Speakers Bureau: Abbott, Amarin, AstraZeneca, Boehringer Ingelheim, DexCom, Lilly, Merck, Novo Nordisk, Xeris, Zealand

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, has the following relevant financial relationships with commercial interests to disclose:

• Consultant: LifeScan, Lilly, Insulet
• Speakers Bureau: DexCom, Medtronic, Abbott Diabetes Care, Novo Nordisk

Erin Shaal, PharmD, and Samir Mistry, PharmD, have no relevant financial relationships with commercial interests to disclose.

Medical Writing and Editorial Support

Nisha Bhide, PharmD, BCPS, has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Dipti Desai, PharmD, CHCP; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms